Comparison of Hip Resurfacing and Cementless Metal-on-metal Total Hip Arthroplasty

NCT ID: NCT00570167

Last Updated: 2009-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare clinical, functional and radiological outcome after hip resurfacing and cementless metal-on-metal total hip arthroplasty.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

While many problems associated with endoprosthetic surgery have been solved, there are still some open questions: In hip replacement one of the most controversial issues is the role and the indications for "resurfacing" (Schmalzried 2005, Hungerford 2005).

Resurfacing In traditional hip replacement, the head of the femur is replaced with a metal head secured to a stem in the femoral canal. In hip resurfacing, the neck of the femur is not cut, and instead the head of the femur is capped with a hemispherical metal ball articulated with an acetabular cup. The concept of resurfacing was developed as early as the 1970s, but it was abandoned due to unsatisfactory results. The procedure started to spark new interest in the 1990s as the results improved due to improvements in the articulation surfaces and fixation techniques (Amstutz 1998), and it has become considerably more common in the 2000s. In Australia, for example, resurfacing procedures accounted for 9% of all hip replacement operations carried out as a consequence of primary osteoarthritis, and their use has increased 17-fold in the 2000s (Australian Orthopedic Association National Joint Replacement Registry).

The partly assumed benefits of hip resurfacing include less bone resection in connection with the procedure, easiness of reoperation (a "conventional" replacement is carried out if reoperation is necessary), smaller risk of dislocation due to the larger head, and more physiological flexibility of the femur as the neck of the femur is not replaced with an inflexible metal stem. The short-term and mid-term results of modern resurfacing procedures presented in the reports of the developer clinics have been encouraging (Daniel 2004, Beaule 2004), but long-term results are lacking. Resurfacing procedures are technically more challenging and have given rise to complications that are not associated with conventional hip replacement, such as fractures of the femoral neck (Shimmin 2005). On the other hand, the socket and the diameter of the ball used in resurfacing procedures and conventional hip replacements are similar, and excellent results have been reached with modern conventional cementless stems (Eskelinen 2005). There are no published studies comparing modern resurfacing prostheses to solutions involving cementless stems with a large head and metal-on-metal articulation surfaces.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2

Total cementless hip arthroplasty with metal-on-metal bearings

Group Type ACTIVE_COMPARATOR

Cementless total hip arthroplasty with m-o-m bearings

Intervention Type PROCEDURE

Cementless monoblock acetabular cup and cementless femoral stem with modular large head and metal-on-metal bearings..

1

Hip resurfacing

Group Type ACTIVE_COMPARATOR

Hip resurfacacing

Intervention Type PROCEDURE

Hip resurfacing with cementless acetabular cup and cemented femoral head

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hip resurfacacing

Hip resurfacing with cementless acetabular cup and cemented femoral head

Intervention Type PROCEDURE

Cementless total hip arthroplasty with m-o-m bearings

Cementless monoblock acetabular cup and cementless femoral stem with modular large head and metal-on-metal bearings..

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BHR (Smith & Nephew, Memphis, TN, USA) BHR-cup and Synergy stem (Smith & Nephew. Memphis, TN, USA)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Primary osteoarthritis of the hip, planned to be treated by hip replacement surgery
2. Normal acetabulum, or no more than mild dysplasia of the acetabulum
3. Aged 18 to 60 years
4. The patient's mother tongue is Finnish

Exclusion Criteria

1. Patient has a secondary osteoarthritis of hip
2. The patient has undergone endoprosthetic surgery of the other hip in the preceding six months, or such a procedure is planned for the patient in the next six months
3. The patient has undergone or is planned to undergo endoprosthetic surgery of the knee or ankle in the next year
4. The patient has undergone surgery of the other hip, knee or ankle with an unsatisfactory outcome
5. The patient has been diagnosed with or is suspected to have an untreated or recurring malignancy or systemic infection
6. A disease treated with cortisone or immunosuppressive medication
7. The patient's cooperation is impaired for any reason
8. Any systemic disease that impairs the patient's mobility
9. Female patients in fertile age who are planning to have children during the study
10. The patient has previously undergone an operation of the hip region that extended below the subcutaneous tissue
11. The patient has experienced a femoral neck fracture
12. The patient has been diagnosed with or is strongly suspected to have osteoporosis (T-score less than or equal to -2.5 SD)
13. The patient has a systemic or metabolic disease that has impaired or is going to impair bone quality
14. A significant cyst (diameter greater than 1 cm) or cysts in the area of the femoral neck
15. Bilateral simultaneous hip arthroplasty
16. Neck-shaft angle 120 degrees or less
17. Deformed femoral head making hip resurfacing impossible
18. Head-neck ratio less than 1.2
19. Avascular necrosis of the femoral head
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kuopio University Hospital

OTHER

Sponsor Role collaborator

University of Turku

OTHER

Sponsor Role collaborator

University of Helsinki

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Helsinki University Central Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ville M Remes, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Helsinki University Central Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kuopio University Hospital

Kuopio, Itä-Suomi, Finland

Site Status

Turku University Hospital

Turku, Lounais-Suomi, Finland

Site Status

Helsinki University Hospital

Helsinki, Uusimaa, Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ISRCTN60907614

Identifier Type: -

Identifier Source: secondary_id

TYH7306

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.